Just a few months ago, the US Panel on Multidistrict Litigation agreed to consolidate Benicar lawsuits into a multidistrict litigation for pretrial proceedings. At the time the motion was filed there were roughly 45 lawsuits filed against Daiichi Sankyo. Since the multidistrict litigation was announced, however, the number of lawsuits added to the action has grown to 915 as of July 15, 2015, according to court documents. Those lawsuits currently sit in MDL 2606, before Judge Robert Kugler in US District Court in New Jersey.
Lawsuits filed against Daiichi Sankyo allege Benicar was not adequately tested before it was released on the market. Plaintiffs claim they suffered sprue-like enteropathy, a serious condition marked by severe diarrhea and weight loss. One lawsuit filed against Daiichi Sankyo claims Benicar was only tested for three months, even though it is generally prescribed for a minimum of six months.
The consolidation of lawsuits for pretrial proceedings is not a comment on their merit but an acknowledgement that they share similar questions of fact, and the discovery process would be more efficient if done as a consolidated action.
READ MORE BENICAR LEGAL NEWS
In January 2015, the US Department of Justice announced that Daiichi Sankyo agreed to pay $39 million to resolve allegations of violations of the False Claims Act. Among the allegations made by the Department of Justice were that Daiichi Sankyo paid illegal kickbacks to doctors to encourage them to prescribe its medications, including Benicar, Welchol and Azor.